Home > Rheumatology > COVID outcomes have improved over time in patients with rheumatic disease

COVID outcomes have improved over time in patients with rheumatic disease

Journal
The Lancet Rheumatology
Reuters Health - 26/01/2021 -  A trends analysis shows that COVID-19 outcomes in patients with rheumatic and musculoskeletal diseases improved as the pandemic continued. "To our knowledge, we provide the first report of improving COVID-19 outcomes, including hospitalization, mechanical ventilation, renal failure, and death, in patients with rheumatic and musculoskeletal diseases in a multicenter US electronic health record database during the ongoing pandemic," the study team writes in The Lancet Rheumatology. Using TriNetX, a large, multicenter, electronic-health-record network, they compared COVID-19 outcomes in patients with rheumatic disease who were treated early in the pandemic (January 20-April 19) and their peers treated later (April 20-July 19). The early cohort include 2,811 patients and the late cohort had 5,729 patients. The groups were matched for demographics, comorbid conditions, laboratory results, glucocorticoid use and prior hospitalizations...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on